Dr. Laura D. Flannery, MD

Dr. Flannery practices at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Flannery's NPI, 1891058582, was assigned on June 19, 2012. Dr. Flannery graduated from Georgetown University School of Medicine in 2012. Dr. Flannery holds Ohio license 35.143003.

Dr. Flannery's primary practice is OhioHealth Riverside Methodist Hospital, at 3535 Olentangy River Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 566-5000.

Dr. Flannery's primary practice is OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth. Dr. Flannery is also affiliated with OhioHealth Grant Medical Center. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Flannery to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flannery practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Flannery's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Flannery's licenses on file in 2 states: Ohio and Massachusetts.

CMS data shows 867 Medicare services from Dr. Flannery across 14 procedure codes in 2024, for 630 Medicare patients. Medicare paid $87,122 for them.

CMS counts 630 Medicare patients who saw Dr. Flannery in 2024. The largest group is 75 to 84, with 262 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flannery's median patient age at 75, with 55% women.

In 2024, Dr. Flannery wrote 540 Medicare Part D claims for 125 patients. 83% of them were for generic drugs. CMS names the drug for 454 of them, across 13 drugs with 11 or more claims each, at $68,767 in total drug cost. In 2023, CMS named 570 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Flannery for performance year 2024, reported as part of a group. Dr. Flannery accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Flannery, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Flannery, published from 2017 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Aortic Valve Stenosis, Heart Valve Prosthesis Implantation and Aortic Valve. Dr. Flannery has published most often in J Soc Cardiovasc Angiogr Interv. Dr. Flannery's most frequent co-authors are Sammy Elmariah, MD, MPH, Nathaniel Blakeslee Langer, MD and Jonathan James Passeri, MD.

CMS Open Payments shows 460 general payments to Dr. Flannery from 29 drug and device companies from 2018 to 2025. Grants make up the largest share, 40% of the total. Medtronic, Inc. paid the most, $14,015.

Dr. Flannery graduated from Georgetown University School of Medicine in 2012.